BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2475 related articles for article (PubMed ID: 17320506)

  • 1. The epigenomics of cancer.
    Jones PA; Baylin SB
    Cell; 2007 Feb; 128(4):683-92. PubMed ID: 17320506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue disruption increases stochastic gene expression thus producing tumors: Cancer initiation without driver mutation.
    Capp JP
    Int J Cancer; 2017 Jun; 140(11):2408-2413. PubMed ID: 28052327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between epigenetic abnormalities and deregulated expression of microRNAs in cancer.
    Farooqi AA; Fuentes-Mattei E; Fayyaz S; Raj P; Goblirsch M; Poltronieri P; Calin GA
    Semin Cancer Biol; 2019 Oct; 58():47-55. PubMed ID: 30742906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation.
    Gasque Schoof CR; Izzotti A; Jasiulionis MG; Vasques Ldos R
    Biomed Res Int; 2015; 2015():634749. PubMed ID: 26618174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Master and servant: epigenetic deregulations as a cause and a consequence of cancer].
    Laget S; Defossez PA
    Med Sci (Paris); 2008; 24(8-9):725-30. PubMed ID: 18789219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of angiogenesis in lung cancer.
    Tan HW; Xu YM; Qin SH; Chen GF; Lau ATY
    J Cell Physiol; 2021 May; 236(5):3194-3206. PubMed ID: 33078404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complexity of epigenetic diseases.
    Brazel AJ; Vernimmen D
    J Pathol; 2016 Jan; 238(2):333-44. PubMed ID: 26419725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratumoral Heterogeneity of the Epigenome.
    Mazor T; Pankov A; Song JS; Costello JF
    Cancer Cell; 2016 Apr; 29(4):440-451. PubMed ID: 27070699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On Epigenetic Plasticity and Genome Topology.
    Lazaris C; Aifantis I; Tsirigos A
    Trends Cancer; 2020 Mar; 6(3):177-180. PubMed ID: 32101721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetics: surveillance team against cancer.
    Klein G
    Nature; 2005 Mar; 434(7030):150. PubMed ID: 15758980
    [No Abstract]   [Full Text] [Related]  

  • 11. Oncogenes and tumor suppressor genes as paradigms in oncogenesis.
    Spandidos DA
    J BUON; 2007 Sep; 12 Suppl 1():S9-12. PubMed ID: 17935284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic regulation of cancer stem cell gene expression.
    Bapat SA
    Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cancer epigenome: its origins, contributions to tumorigenesis, and translational implications.
    Baylin SB
    Proc Am Thorac Soc; 2012 May; 9(2):64-5. PubMed ID: 22550245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutated Chromatin Regulatory Factors as Tumor Drivers in Cancer.
    Koschmann C; Nunez FJ; Mendez F; Brosnan-Cashman JA; Meeker AK; Lowenstein PR; Castro MG
    Cancer Res; 2017 Jan; 77(2):227-233. PubMed ID: 28062403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
    Baylin SB; Ohm JE
    Nat Rev Cancer; 2006 Feb; 6(2):107-16. PubMed ID: 16491070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Smad"eningly erratic: target gene methylation determines whether TGFbeta promotes or suppresses malignant glioma.
    Kesari S; Jackson-Grusby L; Stiles CD
    Dev Cell; 2007 Mar; 12(3):324-5. PubMed ID: 17336898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concise review: roles of polycomb group proteins in development and disease: a stem cell perspective.
    Rajasekhar VK; Begemann M
    Stem Cells; 2007 Oct; 25(10):2498-510. PubMed ID: 17600113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic stochasticity, nuclear structure and cancer: the implications for medicine.
    Feinberg AP
    J Intern Med; 2014 Jul; 276(1):5-11. PubMed ID: 24635672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered primary chromatin structures and their implications in cancer development.
    Ferraro A
    Cell Oncol (Dordr); 2016 Jun; 39(3):195-210. PubMed ID: 27007278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Models of oncogenesis: an endless world?].
    Larsen CJ
    Bull Cancer; 2013 Jun; 100(6):555-60. PubMed ID: 23719507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 124.